Legal Opinion
In re Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability Litigation
District Court, E.D. Pennsylvania
Decided August 30, 2012No. MDL No. 1203; Civil Action Nos. 11-20001, 99-20593PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM IN SUPPORT OF SEPARATE PRETRIAL ORDER NO. 8933
BARTLE, District Judge.
Plaintiffs Jamie D. Cheek and Valarie Farmer have each filed an action against defendant Wyeth, LLC (“Wyeth”)1 alleging that she suffers from primary pulmonary hypertension (“PPH”)2 as a result of ingestion of Wyeth’s appetite-suppressant drugs fenfluramine, marketed as Pondimin, and dexfenfluramine, marketed as Redux (“Diet Drugs”). Before the court is the motion of Wyeth to enjoin Ms. Cheek and Ms. Farmer from continuing with their lawsuits in the United States District for the District of South Carolina and the…
2Cases cited19 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Frye v. United StatesCourt of Appeals for the D.C. Circuit · 1923
- In Re Paoli Railroad Yard PCB LitigationCourt of Appeals for the Third Circuit · 1994
14 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Echeverria v. Johnson, California Court of Appeal, 5th District2019
- In re Zoloft (Sertralinehydrochloride) Products Liability LitigationDistrict Court, E.D. Pennsylvania · 2016
- Valido-Shade v. Wyeth LLCDistrict Court, E.D. Pennsylvania · 2014
- Bockus v. Merck & Co., Inc.District Court, E.D. Pennsylvania · 2023
- Johnson & Johnson Talcum Powder CasesCalifornia Court of Appeal · 2019
2 more not listed; retrieve them via the Exa API.